Phase I study of temozolamide (TMZ) combined with procarbazine (PCB) in patients with gliomas - Wikidata - wikimedia - TriplyDB

Phase I study of temozolamide (TMZ) combined with procarbazine (PCB) in patients with gliomas

Phase I study of temozolamide (TMZ) combined with procarbazine (PCB) in patients with gliomas

http://www.wikidata.org/entity/Q33349020

about

Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas.Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates.Survival analysis of HDR brachytherapy versus reoperation versus temozolomide alone: a retrospective cohort analysis of recurrent glioblastoma multiforme.In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model.Establishment of a primary pleomorphic xanthoastrocytoma cell line: in vitro responsiveness to some chemotherapeutics.Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial.

P2860

Q24683022-27FF033E-76FA-47BE-9223-6E76D4DB49C9 Q33973844-75425F81-AFF0-4902-891B-E99A2D229AAC Q36668246-25D4D6DC-F6BD-4EDB-8378-4D4790FA5935 Q36730160-AA2B429E-3FC0-4722-9EAD-1B6B28C76413 Q38391466-1AD811BE-B991-4830-B07B-382969CC2E49 Q39532769-DB885BD4-4F09-48FF-B945-1CB72D3CEDC7 Q39953290-6C3B992B-6476-4801-865C-3AB95DED53B0

P2860

Phase I study of temozolamide (TMZ) combined with procarbazine (PCB) in patients with gliomas

http://www.wikidata.org/entity/Q33349020

description

2003 nî lūn-bûn

@nan

2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Phase I study of temozolamide ...... (PCB) in patients with gliomas

@ast

Phase I study of temozolamide ...... (PCB) in patients with gliomas

@en

type

label

Phase I study of temozolamide ...... (PCB) in patients with gliomas

@ast

Phase I study of temozolamide ...... (PCB) in patients with gliomas

@en

prefLabel

Phase I study of temozolamide ...... (PCB) in patients with gliomas

@ast

Phase I study of temozolamide ...... (PCB) in patients with gliomas

@en

P1433

Q33349020-5125CDD7-B8A1-4EAC-9400-A26A862C100E

P1476

Q33349020-57D6643F-AA7B-4A58-BB51-08DC74744B23

P2093

Q33349020-81AA51F1-7426-4932-AC9E-B3BC5E200528

Q33349020-D20145C4-D80F-4B50-8142-955F3EB7240F

Q33349020-D4127D7E-B5F3-4467-9784-A9B184516C21

P2860

Q33349020-0CB4FF28-2589-4083-AEC3-4CE77FC26597

Q33349020-2F177DBB-FE7E-4A08-8B28-AACFD3E4EDC9

Q33349020-304091C8-0A39-46B9-BA34-D4EE7F170A50

Q33349020-31175F28-F505-419F-A630-743CE339A7C1

Q33349020-42D39D3A-7D86-4AA1-9902-329844645DE0

Q33349020-54D0E327-2D28-4C6B-9F01-107D8914313E

Q33349020-5DE03A6B-B4B5-45B8-A828-DCF053004BCF

Q33349020-64537D33-F11B-480D-846F-4689253F20C6

Q33349020-6AC0BB91-E3EE-4C25-B420-E180ED0B1B44

Q33349020-6E8C9D80-3A93-4E2E-AB75-0C3DBD4A5310

P2888

Q33349020-759F18A0-5AB9-48E3-9812-A0AD745EBEB8

P304

Q33349020-6EDCDD10-798D-413B-9EEF-3C0000251090

P31

Q33349020-329C7924-CFF1-4B15-ADE1-133EA1E94B92

P356

Q33349020-D49A5952-50C1-48BC-A30C-FD4289E07D33

P407

Q33349020-1E5AE109-5E25-4BA9-963F-2EFD0FC2FC42

P433

Q33349020-D29FB6F6-F69B-4C31-AFC1-6CB996C3592D

P478

Q33349020-F4AA6EFE-60A4-44B8-B73A-22465BCC610E

P577

Q33349020-5556F144-7B7E-47D8-9C18-0BA53A496713

P5875

Q33349020-6AFCAF61-28BD-476A-9840-576357965951

P6179

Q33349020-DA773F33-9E23-4452-97FD-797443B3CCFF

P698

Q33349020-4E3DD21F-1CC3-495E-B9C4-8CEBF7DA08D2

P932

Q33349020-4341F993-A19E-4EF6-887B-339E6DEBEAE8

P356

P1433

British Journal of Cancer

P1476

Phase I study of temozolamide ...... (PCB) in patients with gliomas

@en

P2093

E S Newlands

http://www.w3.org/2001/XMLSchema#string

S Zaknoen

http://www.w3.org/2001/XMLSchema#string

T Foster

http://www.w3.org/2001/XMLSchema#string

P2860

Phase I trial of temozolomide (CCRG 81045: M&B; 39831: NSC 362856)

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.

Phase I trial of temozolomide using an extended continuous oral schedule.

Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine.

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

The role of chemotherapy in the treatment of gliomas in adults.

Does chemotherapy benefit the patient with a central nervous system glioma?

Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro.

Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells.

Antitumor imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one , a novel broad-spectrum antitumor agent.

P2888

P304

248-251

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6601043

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P577

2003-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10657790

http://www.w3.org/2001/XMLSchema#string

P6179

1048666246

http://www.w3.org/2001/XMLSchema#string

P698

12865911

http://www.w3.org/2001/XMLSchema#string

P932

2394263

http://www.w3.org/2001/XMLSchema#string